Table 2.
Group A | Group B | P value | |
---|---|---|---|
Use of heavy liquid (yes:no) | 29:12 | 27:9 | 0.675* |
Phacovitrectomy (yes:no) | 4:37 | 5:31 | 0.726* |
Laser photocoagulation number (shots) | 421.3 ± 131.5 | 450.9 ± 150.3 | 0.715† |
Primary anatomic success (yes:no [%]) | 38:3 (92.7) | 35:1 (97.2) | 0.618* |
Causes of failure (number of eyes) | 1.000* | ||
New retinal breaks | 2 | 1 | |
PVR | 1 | 0 | |
Final anatomic success (%) | 100 | 100 | 1.000* |
Postoperative cataract surgery (number) | |||
Phakic eyes after primary RD repair | 31 | 26 | 0.735* |
Underwent secondary cataract surgery | 7 | 13 | 0.031* |
Remained phakic until the final follow-up | 24 | 13 | 0.049* |
Eyes underwent Nd: YAG subcapsulotomy | 4 | 12 | 0.068* |
Postoperative interval to have cataract surgery (months) | 10.3 ± 3.0 | 9.9 ± 2.9 | 0.797‡ |
Postoperative logMAR BCVA (Snellen equivalent) | |||
Day 1 | 1.41 ± 0.60 (20/514) | 2.45 ± 0.23 (20/5637) | <0.001† |
Week 1 | 0.96 ± 0.51 (20/182) | 1.18 ± 0.40 (20/303) | 0.008‡ |
Month 1 | 0.86 ± 0.37 (20/145) | 1.08 ± 0.29 (20/240) | 0.003‡ |
Month 3 | 0.72 ± 0.39 (20/105) | 0.79 ± 0.30 (20/123) | 0.182‡ |
Month 6 | 0.63 ± 0.34 (20/85) | 0.61 ± 0.27 (20/81) | 0.769† |
Final follow-up | 0.42 ± 0.30 (20/53) | 0.43 ± 0.21 (20/54) | 0.404‡ |
PVR proliferative vitreoretinopathy, RD retinal detachment, Nd: YAG neodymium-doped yttrium aluminum garnet, logMAR logarithm of minimal angle of resolution, BCVA best corrected visual acuity
Statistical analysis: * = χ2 analysis; † = unpaired t test; ‡ = unpaired Mann-Whitney test
Continuous values presented as mean ± standard deviation